Bvf Inc Forward Pharma A/S Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.24 - $6.03 $343,011 - $487,820	80,899 Added 18.69%	513,791 $2.23 Million
Q3 2021 Nov 15, 2021	SELL	$5.97 - $17.66 $570,863 - $1.69 Million	-95,622 Reduced 18.09%	432,892 $2.99 Million
Q2 2021 Aug 16, 2021	SELL	$6.77 - $8.6 $804,174 - $1.02 Million	-118,785 Reduced 18.35%	528,514 $4.55 Million
Q2 2020 Aug 14, 2020	SELL	$5.16 - $7.77 $1.44 Million - $2.16 Million	-278,425 Reduced 30.08%	647,299 $3.97 Million
Q1 2020 May 15, 2020	BUY	$4.92 - $7.7 $4.55 Million - $7.13 Million	925,724 New	925,724 $5.38 Million

Ticker FWP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,091,180
Market Cap $18.2M
Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.